Core Viewpoint - Zhongsheng Group predicts that Yunzhisheng (09678) will experience accelerated revenue growth over the next three years, with projected revenues of 1.236 billion, 1.923 billion, and 2.918 billion yuan for 2025, 2026, and 2027 respectively, representing growth rates of 31.6%, 55.6%, and 51.7%, and expects the company to achieve profitability in 2026 [1] Group 1 - Yunzhisheng is a pioneer in AGI technology in China, being one of the first companies to commercialize deep learning voice technology and integrate multimodal technology [2] - The company has developed a matrix of multimodal large models and specialized industry large models, with its UniGPT-Med ranking first in three projects in the latest MedBench 4.0 evaluation, demonstrating a hallucination rate of less than 3%, leading the industry [2] Group 2 - The company has established partnerships with top-tier hospitals such as Peking Union Medical College Hospital and Hunan Xiangya Hospital, covering 40% of the top 100 hospitals in China, creating a solid competitive advantage through its vast medical data assets [3] - The high-quality data training forms an efficient data flywheel, with significant application potential in medical insurance and commercial health insurance cost reduction [3] Group 3 - The company employs a dual-platform strategy, utilizing MaaS for high-end clients through private deployment of regional/industry large models, while SaaS focuses on standardized applications for small and medium clients, facilitating commercial monetization [4] Group 4 - The smart living business continues to grow steadily, with multimodal interactions implemented in various transportation sectors, and deep collaborations with leading companies like TCL and Gree in the home appliance sector [5] - Smart cockpit solutions have been widely adopted in mainstream vehicle models such as SAIC's Zhiji L6 and Geely's Xingrui [5]